Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.0213 | uM | 7473.091 | 1.1545 | 1.1272 | 2.3297 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.107 | uM | 7473.091 | 1.2873 | 1.2290 | 2.3297 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.533 | uM | 7473.091 | 1.3396 | 1.2675 | 2.3297 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 2.67 | uM | 7473.091 | 1.3010 | 1.2391 | 2.3297 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 13.3 | uM | 7473.091 | 1.0845 | 1.0709 | 2.3297 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 66.7 | uM | 7473.091 | 1.1810 | 1.1480 | 2.3297 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.000171 | uM | 7474.09 | 1.0664 | 1.0534 | 2.4405 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.000853 | uM | 7474.09 | 1.0048 | 1.0040 | 2.4405 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.00427 | uM | 7474.09 | 0.9202 | 0.9330 | 2.4405 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.0213 | uM | 7474.09 | 0.9909 | 0.9925 | 2.4405 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.107 | uM | 7474.09 | 1.0720 | 1.0578 | 2.4405 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.533 | uM | 7474.09 | 1.0153 | 1.0125 | 2.4405 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 2.67 | uM | 7474.09 | 1.0970 | 1.0773 | 2.4405 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 13.3 | uM | 7474.09 | 1.1035 | 1.0823 | 2.4405 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 66.7 | uM | 7474.09 | 1.1395 | 1.1099 | 2.4405 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.000171 | uM | 7475.091 | 1.2728 | 1.1881 | 2.6839 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.000853 | uM | 7475.091 | 1.3326 | 1.2258 | 2.6839 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.00427 | uM | 7475.091 | 1.1298 | 1.0930 | 2.6839 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.0213 | uM | 7475.091 | 1.0731 | 1.0533 | 2.6839 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.107 | uM | 7475.091 | 1.3236 | 1.2202 | 2.6839 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.533 | uM | 7475.091 | 1.2660 | 1.1837 | 2.6839 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 2.67 | uM | 7475.091 | 1.1295 | 1.0928 | 2.6839 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 13.3 | uM | 7475.091 | 1.2059 | 1.1445 | 2.6839 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 66.7 | uM | 7475.091 | 1.3153 | 1.2150 | 2.6839 | |
| Hs 578T | TNBC | Basal B | Erlotinib | EGFR | ErbB | 0.0000853 | uM | 10379.092 | 0.9733 | 0.9792 | 2.5811 |